RxDoctor Payments Data

Arnold Wilson, MD

Orthopedic Surgery · Bronx, NYNPI 1053422519

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 52 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Kowa Pharmaceuticals America, Inc. at 36.8% of the total. Reporting peaked in 2022 at $520 and has fallen 53.9% since, to $240 in 2025.

$1,439in general payments, 2019–2025

Across 52 payments — averaging $27.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kowa Pharmaceuticals America, Inc.$529
  • Amgen$328
  • Zimmer Biomet$292
  • Smith+Nephew$124
  • Nuvasive Specialized Orthopedics, Inc.$99
  • Stryker$53
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$1,439100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,439 in reported general payments places this provider in the 60th percentile of 91 orthopedic surgery providers in New York.

See all orthopedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$72,642
Medicare patients
150
Services billed
2,368

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium74$9,503
Meloxicam463$1,233
Naproxen87$459
Ibuprofen14$94
Tramadol Hcl31$90

Paid to pharmacies, not to this prescriber.

Other orthopedic surgery in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →